Frank Stenner

4PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 29, 2026
Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

|Nov 19, 2025
A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinoma.

Silvia Guglietta, Anne Bärenwaldt, Anthony Sonrel

|Apr 17, 2024
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes.

David König, Michael T Sandholzer, Sarp Uzun

|Sep 22, 2019
Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX).

Heike Liewen, Norbert Markuly, Heinz Läubli

Pageof 1

Frequent Collaborators

3 joint publications

Alfred Zippelius

2 joint publications

Lukas Bubendorf

2 joint publications

Petra Herzig

2 joint publications

Heinz Läubli